Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122567322 | 12256732 | 2 | F | 201409 | 20160705 | 20160412 | 20160708 | EXP | US-PFIZER INC-2016197377 | PFIZER | 53.00 | YR | F | Y | 0.00000 | 20160708 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122567322 | 12256732 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, DAILY | N | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | |||||||
122567322 | 12256732 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 20 MG, 1X/DAY | N | 20699 | 20 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
122567322 | 12256732 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, DAILY (50MG, 1 TABLET TWICE DAILY) | U | 21446 | 50 | MG | CAPSULE, HARD | BID | |||||
122567322 | 12256732 | 4 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | 900 MG, DAILY (600MG, 1/2 TABLET 3 TIMES DAILY) | U | 20235 | 300 | MG | TID | ||||||
122567322 | 12256732 | 5 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK (250-50MCG/DOSE) | 0 | |||||||||||
122567322 | 12256732 | 6 | C | PROVENTIL HFA | ALBUTEROL SULFATE | 1 | UNK, AS NEEDED (108(90BASE) 1-2 PUFFS EVERY 4 HOURS AS NEEDED) | 0 | |||||||||||
122567322 | 12256732 | 7 | C | CLONIDINE HCL | CLONIDINE HYDROCHLORIDE | 1 | 0.1 MG, 1X/DAY (0.1MG TABLET AT NIGHT) | 0 | .1 | MG | TABLET | QD | |||||||
122567322 | 12256732 | 8 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | UNK, AS NEEDED (HYDROCODONE-10MG, ACETAMINOPHEN-325MG;1 TABLET DAILY AS NEEDED) | 0 | TABLET | |||||||||
122567322 | 12256732 | 9 | C | OXYBUTYNIN CHLORIDE. | OXYBUTYNIN CHLORIDE | 1 | Oral | 10 MG, DAILY (5MG, 1 TABLET TWICE DAILY) | 0 | 5 | MG | TABLET | BID | ||||||
122567322 | 12256732 | 10 | C | DIAZEPAM. | DIAZEPAM | 1 | Oral | 1/2-1 TABLET DAILY AS NEEDED | 0 | TABLET | |||||||||
122567322 | 12256732 | 11 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET | |||||||
122567322 | 12256732 | 12 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, DAILY | 0 | 25 | MG | TABLET | |||||||
122567322 | 12256732 | 13 | C | IPRATROPIUM-Albuterol | ALBUTEROLIPRATROPIUM | 1 | UNK, EVERY 4 HRS (0.5-2.5 (3)MG/3ML INH SOL, ONE VIAL EVERY 4 HRS) | 0 | SOLUTION FOR INFUSION | ||||||||||
122567322 | 12256732 | 14 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 100 UG, 1X/DAY (TAKE 1 TABLET EMPTY STOMACH 30 MINUTES BEFORE BREAKFAST) | 0 | 100 | UG | TABLET | QD | ||||||
122567322 | 12256732 | 15 | C | CLINDAMYCIN HYDROCHLORIDE. | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | 150 MG, 3X/DAY | 0 | 150 | MG | CAPSULE | TID | ||||||
122567322 | 12256732 | 16 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG, DAILY SOMETIMES. | 0 | 20 | MG | TABLET | |||||||
122567322 | 12256732 | 17 | C | ASPIRIN 81 | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG | |||||||||
122567322 | 12256732 | 18 | C | ALBUTEROL. | ALBUTEROL | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122567322 | 12256732 | 1 | Depression |
122567322 | 12256732 | 3 | Back pain |
122567322 | 12256732 | 6 | Dyspnoea |
122567322 | 12256732 | 7 | Sleep disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122567322 | 12256732 | OT |
122567322 | 12256732 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122567322 | 12256732 | Anxiety | |
122567322 | 12256732 | Arthritis | |
122567322 | 12256732 | Back pain | |
122567322 | 12256732 | Breast mass | |
122567322 | 12256732 | Chronic obstructive pulmonary disease | |
122567322 | 12256732 | Depression | |
122567322 | 12256732 | Dermal cyst | |
122567322 | 12256732 | Lymphadenopathy | |
122567322 | 12256732 | Muscle spasms | |
122567322 | 12256732 | Salivary gland enlargement | |
122567322 | 12256732 | Upper respiratory tract infection | |
122567322 | 12256732 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122567322 | 12256732 | 2 | 2014 | 0 | ||
122567322 | 12256732 | 3 | 2014 | 0 | ||
122567322 | 12256732 | 4 | 20160115 | 0 | ||
122567322 | 12256732 | 5 | 20140926 | 0 | ||
122567322 | 12256732 | 6 | 20140926 | 0 | ||
122567322 | 12256732 | 7 | 20141216 | 0 | ||
122567322 | 12256732 | 8 | 20150209 | 0 | ||
122567322 | 12256732 | 9 | 20151016 | 0 | ||
122567322 | 12256732 | 10 | 20151208 | 0 | ||
122567322 | 12256732 | 11 | 20151208 | 0 | ||
122567322 | 12256732 | 12 | 20151214 | 0 | ||
122567322 | 12256732 | 13 | 20160107 | 0 | ||
122567322 | 12256732 | 14 | 20160107 | 0 | ||
122567322 | 12256732 | 15 | 20160121 | 0 | ||
122567322 | 12256732 | 16 | 20160205 | 0 |